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Background: Renal cell carcinoma (RCC) is a tumor known for its unusual presentations and high rate of
metastasis. Metastasis to lung, liver, bone and brain are common, but to skeletal muscle(SM) is very rare. Because
only 11% of the RCC metastases to SM present after 10 years of initial presentation, there is no general consensus
for its annual surveillance.
Methods: We report a case of a 58 year old male with a history of RCC, initially diagnosed 11 years ago, who
presented with a large SM mass. A large mass measuring more than 25 cm was located in left posterior thigh and
was present for more than a year. It initially was diagnosed as a large blood clot and was treated with warfarin for
more than 6 months. Clinical work up including FDG-PET/CT and MRI raised the possibility of a tumor, but a
negative biopsy made the diagnosis uncertain. Because of high suspicion for a tumor, patient underwent a
complete resection of the mass.
Results: The resected mass measuring 28 × 18 × 7 cm was detailed as the largest skeletal muscle metastasis from
RCC ever reported.
Conclusion: This case emphasizes the importance of maintaining a high suspicion for metastasis even in less
common metastatic sites mainly in patients with a history of RCC. It also highlights the importance of annual
surveillance for metastasis in patients with RCC even after 10 years of initial presentation using FDG-PET/CT.
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Skeletal muscle is a rare site of metastasis accounting for
<1% of metastasis.(Pompo et al. 2008; Camnasio et al.
2010; Gözen et al. 2009) Lungs and GI tumors are com-
mon, but rarely RCC, head and neck carcinomas can
also present with skeletal metastasis. (Pompo et al. 2008;
Gözen et al. 2009) In recent large autopsy series, it was
found that less than <1% of the RCCs metastasized to
skeletal muscle. (Pompo et al. 2008; Ali et al. 2011;
Camnasio et al. 2010). From recent review of English lit-
erature, only 35 cases of skeletal muscle metastasis from
RCC have been reported (Sountoulides et al. 2011) and
of which only 2 to biceps femoris muscle (Ali et al. 2011).
Atypical presentations and unusual sites of metastasis
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in any medium, provided the original work is pWe describe an unusual presentation of skeletal muscle
metastasis from RCC and emphasize on the annual surveil-
lance for metastatic RCC even after curative nephrectomy.Case
We present a 58 year old male with an unusual posterior
thigh mass for more than a year. Patient had a past medical
history significant for RCC, initially diagnosed at stage II,
11 years ago followed by left nephrectomy. Patient also had
metastasis to tail of the pancreas and tip of spleen 6 years
ago which was followed by total resection of pancreas and
spleen. Patient was followed up for RCC and was last seen
2 years ago when his PET/CT showed slightly increased
hypermetabolic area in the biceps femoris muscle which
was interpreted as a muscle injury secondary to the rarity
of the metastasis to the skeletal muscle from RCC. Patient
during the current follow up visit developed a large mass in
the posterior side of the thigh which was present for more
than a year. As per patient, the mass initially was diagnosedn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Axial PET-IMG/CT shows hypermetabolic activity with standard uptake of 3.8 to 4.1 in left biceps femoris.
Figure 2 A coronal PET-IMG/CT demonstrating significant enlargement of soft tissue and fatty components in the biceps femoris
muscle belly. Multiple serpiginous vessels are seen coursing through the soft tissue and surrounding edema.
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Figure 3 T1-weighted axial MR image with fat saturation shows an encapsulated soft tissue mass with in the left biceps femoris muscle.
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by his primary care physician with warfarin for more than 6
months. However, the mass progressively increased in size.
Patient did not mention of any other constitutional symp-
toms. On physical examination, a painless, tense mass along
the length of biceps femoris muscle measuring more thanFigure 4 A T2- weighted axial MR image showing avid enhancement of
of various mesenchymal components including fat. Multiple serpiginous25 cm was found in the posterior aspect of the left thigh.
The mass was hypervascular and numerous varicosities of
different sizes were noticeable on the surface. Patient was
imaged using FDG-PET/CT which showed hypermetabolic
activity with an uptake value of 3.8 to 4.1 in biceps femoris
muscle with multiple serpiginous vessels throughout thesoft tissue components throughout the region indicating presence
enlarged draining and feeding vessels can also be identified.
Figure 5 Light microscopy 4X showing malignant cells with clear cytoplasm invading into surrounding soft tissue and skeletal muscle.
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or an angiosarcoma. This was followed by MRI to better
understand the morphology of the tumor, demonstrating a
mesenchymal component in an encapsulated mass, raising
the possibility of a liposarcoma or an angiosarcoma. A core
tissue biopsy was done which demonstrated well defined
adipose tissue but because of high suspicion for ma-
lignancy, patient underwent preembolization followed
by surgical resection. A 28 x 17 x 7 cm resected massFigure 6 Light microscopy 40X showing malignant cells with clear cy
nucleoli. It was positive for cytokeratin, RCC, p-NRA and negative for CK7,was determined to be metastasis from his primary RCC
(Figures 1, 2, 3, 4, 5 and 6).
Patient on his follow up with a whole body FDG-PET/
CT was also found to have metastasis to his lateral ventricle
in the brain from the RCC.
Discussion
Renal cell carcinoma accounts for approximately 3% of all
adult tumors (Sountoulides et al. 2011; Gözen et al. 2009)toplasm along with distinct cell membranes and prominent
CK20, S-100, MART-1, and PAS.
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as initial presentation or late complication (Sountoulides
et al. 2011; Gözen et al. 2009). Because of complex lymph-
atic drainage and early hematogenous spread (Gözen et al.
2009), atypical presentations and distant metastasis remain
characteristic of RCC (Picchio et al. 2010; Ali et al. 2011;
Schatteman et al. 2002; Sakamoto et al. 2007). Lung paren-
chyma, liver and bone are the common metastatic sites but
it can also rarely spread to brain, pancreas, and skeletal
muscle (Sountoulides et al. 2011; Pompo et al. 2008;
Picchio et al. 2010; Hur et al. 2007; Taira et al. 2005; Gözen
et al. 2009; Sakamoto et al. 2007).
It has been reported that approximately 0.4% of RCC
metastasizes to skeletal muscle (Ali et al. 2011; Gözen et al.
2009; Sakamoto et al. 2007). Despite its rich blood supply
and large surface area, skeletal muscle metastasis is very
rare (Pompo et al. 2008; Pompo et al. 2009). Presence of
protease inhibitors in the basement membrane inhibiting
cell invasion, increased lactic acid levels and acidic environ-
ment interfering with tumor cell growth, presence of
peptidic factors preventing the metastasis, muscular con-
tractions dislodging the anchored tumor cells all provide
insight into the rarity of skeletal metastasis. (Pompo et al.
2008; Taira et al. 2005; Ali et al. 2011; Gözen et al. 2009).
Additionally, the scarcity or absence of specific receptors
which influence the metastatic potential in RCC, the onco-
gene transgene bypassing the primary site and pre-selection
of the organs of metastasis with formation of favorable en-
vironment by bone marrow cells may provide further ex-
planation (Pompo et al. 2008).
RCC commonly metastasizes to soft tissues as a solitary
soft tissue deposit developing any time between 6 months
to 19 years, with the greatest risk in the first 5 years after
initial presentation (Ali et al. 2011). McNichols et.al reported
that only 11% of skeletal metastasis occurs after 10 years of
primary tumor presentation (Hur et al. 2007; Camnasio
et al. 2010; Sakamoto et al. 2007). The mass presented in this
case, measuring 28 x 17 x 7 cm, is larger than previously
reported sizes of these metastatic tumors, which have been
in the range of 1.5 to 16 cm (Pompo et al. 2008).
Differentiating the unusual skeletal metastasis from
other tumors still remains a diagnostic challenge and is
pivotal because of the great differences in their treatment
and prognosis (Pompo et al. 2008; Gözen et al. 2009).
FDG-PET/CT, MRI helps in understanding the morph-
ology of the tumor and a tissue biopsy is needed in most
cases to make a definitive diagnosis (Hur et al. 2007;
Sakamoto et al. 2007).
Location, size, and lack of pain in our patient were
suspicious for diagnosis of soft tissue sarcomas (Pompo
et al. 2008). Skeletal muscle metastasis as reported be-
fore presents as a painful mass and averages around 5.4
cm in size (Pompo et al. 2008). Presence of a hypervascular
and large amount of varicosities was consistent with ahemangioma or angiosarcoma. Presence of the tumor in
the skeletal belly is consistent with rhabdomyosarcoma.
Though MRI and FDG-PET/CT could identify the tumor,
they were not sufficient to make a definitive diagnosis. Tis-
sue biopsy, known to have previously reported incorrect
diagnoses in 13.5% of the cases in a study (Picchio et al.
2010), was negative in our case. The tumor mass on resec-
tion was differentiated on histopathology as a metastasis
from clear cell RCC.
FDG-PET/CT is an effective tool in surveillance of
RCC, known for its distant and unusual sites of metasta-
sis (Picchio et al. 2010). It allows scanning the body in a
single procedure combining functional information from
PET which can be very useful in small sized tumors and
anatomical details of CT (Picchio et al. 2010). Recent
studies reported that FDG-PET/CT results are equivocal
to any other modality in surveillance of metastasis in
RCC (Picchio et al. 2010). To our knowledge no specific
guidelines have been mentioned previously about sur-
veillance in RCC after 10 years on an annual basis even
for high grade tumors (>Pt2).
Conclusion
We recommend maintaining a high level of suspicion
for metastasis from RCC in a musculo-skeletal mass in a
patient with RCC, even after curative nephrectomy. Be-
cause of advancement in treatment modalities, resulting
in better survival rates, late presentation of the metastasis
in RCC is increasing. We therefore recommend continu-
ing intensive follow up for surveillance of the metastasis
in RCC mainly in high grade tumors even after 10 years of
initial presentation of the tumor or long disease free
interval.
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